Lori Lyons-Williams Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Lori Lyons-Williams.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Lori Lyons-Williams. Lori Lyons-Williams is Director in FIVE PRIME THERAPEUTICS INC ($FPRX) and Chief Commercial Officer in Dermira, Inc. ($DERM).
Latest Insider Trading Transactions of Lori Lyons-Williams
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Lyons-Williams Lori | Director | Option Exercise | D | 4.14 | 20,000 | 82,800 | 0 | |
| Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Lyons-Williams Lori | Director | Option Exercise | D | 6.30 | 25,000 | 157,500 | 0 | |
| May 15 2020 | FPRX | FIVE PRIME THERAPE ... | Lyons-Williams Lori | Director | Option Exercise | A | 4.14 | 20,000 | 82,800 | 20,000 | |
| Feb 24 2020 | DERM | Dermira, Inc. | Lyons-Williams Lori | Chief Commercial Of ... | Option Exercise | D | 0.00 | 15,000 | 0 | 0 | |
| Feb 24 2020 | DERM | Dermira, Inc. | Lyons-Williams Lori | Chief Commercial Of ... | Option Exercise | D | 0.00 | 30,000 | 0 | 0 | |
| Feb 24 2020 | DERM | Dermira, Inc. | Lyons-Williams Lori | Chief Commercial Of ... | Option Exercise | D | 0.00 | 6,378 | 0 | 0 | |
| Feb 24 2020 | DERM | Dermira, Inc. | Lyons-Williams Lori | Chief Commercial Of ... | Option Exercise | D | 7.42 | 65,000 | 482,300 | 0 | |
| Feb 24 2020 | DERM | Dermira, Inc. | Lyons-Williams Lori | Chief Commercial Of ... | Option Exercise | D | 28.25 | 63,750 | 1,800,938 | 0 | |
| Feb 24 2020 | DERM | Dermira, Inc. | Lyons-Williams Lori | Chief Commercial Of ... | Option Exercise | D | 31.87 | 100,000 | 3,187,000 | 0 | |
| Feb 24 2020 | DERM | Dermira, Inc. | Lyons-Williams Lori | Chief Commercial Of ... | Sell | D | 18.75 | 25,401 | 476,269 | 0 | 25.4 K to 0 (-100.00 %) |
| Aug 19 2019 | DERM | Dermira, Inc. | Lyons-Williams Lori | Chief Commercial Of ... | Option Exercise | M | 0.00 | 3,189 | 0 | 6,378 | |
| Aug 19 2019 | DERM | Dermira, Inc. | Lyons-Williams Lori | Chief Commercial Of ... | Payment of Exercise | F | 7.91 | 1,582 | 12,514 | 25,401 | 27 K to 25.4 K (-5.86 %) |
| Aug 19 2019 | DERM | Dermira, Inc. | Lyons-Williams Lori | Chief Commercial Of ... | Buy | M | 0.00 | 3,189 | 0 | 26,983 | 23.8 K to 27 K (+13.40 %) |
| Jun 25 2019 | FPRX | FIVE PRIME THERAPE ... | Lyons-Williams Lori | Director | Option Exercise | A | 6.30 | 25,000 | 157,500 | 25,000 | |
| May 21 2019 | DERM | Dermira, Inc. | Lyons-Williams Lori | Chief Commercial Of ... | Option Exercise | M | 0.00 | 30,000 | 0 | 30,000 | |
| May 21 2019 | DERM | Dermira, Inc. | Lyons-Williams Lori | Chief Commercial Of ... | Payment of Exercise | F | 10.50 | 10,374 | 108,927 | 23,794 | 34.2 K to 23.8 K (-30.36 %) |
| May 21 2019 | DERM | Dermira, Inc. | Lyons-Williams Lori | Chief Commercial Of ... | Buy | M | 0.00 | 30,000 | 0 | 34,168 | 4.2 K to 34.2 K (+719.77 %) |
| Feb 14 2019 | DERM | Dermira, Inc. | Lyons-Williams Lori | Chief Commercial Of ... | Option Exercise | A | 0.00 | 15,000 | 0 | 15,000 | |
| Feb 14 2019 | DERM | Dermira, Inc. | Lyons-Williams Lori | Chief Commercial Of ... | Option Exercise | A | 7.42 | 65,000 | 482,300 | 65,000 | |
| Aug 17 2018 | DERM | Dermira, Inc. | Lyons-Williams Lori | Chief Commercial Of ... | Option Exercise | M | 0.00 | 1,063 | 0 | 9,567 | |
| Aug 17 2018 | DERM | Dermira, Inc. | Lyons-Williams Lori | Chief Commercial Of ... | Option Exercise | A | 0.00 | 60,000 | 0 | 60,000 | |
| Aug 17 2018 | DERM | Dermira, Inc. | Lyons-Williams Lori | Chief Commercial Of ... | Payment of Exercise | F | 9.58 | 368 | 3,525 | 2,616 | 3 K to 2.6 K (-12.33 %) |
| Aug 17 2018 | DERM | Dermira, Inc. | Lyons-Williams Lori | Chief Commercial Of ... | Buy | M | 0.00 | 1,063 | 0 | 2,984 | 1.9 K to 3 K (+55.34 %) |
| Feb 16 2018 | DERM | Dermira, Inc. | Lyons-Williams Lori | Chief Commercial Of ... | Option Exercise | A | 0.00 | 10,630 | 0 | 10,630 | |
| Feb 16 2018 | DERM | Dermira, Inc. | Lyons-Williams Lori | Chief Commercial Of ... | Option Exercise | A | 28.25 | 63,750 | 1,800,938 | 63,750 | |
| Jan 10 2017 | DERM | Dermira, Inc. | Lyons-Williams Lori | Chief Commercial Of ... | Option Exercise | A | 31.87 | 100,000 | 3,187,000 | 100,000 |
Page: 1